The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)
Open accessAbstract
BACKGROUND: There is increasing evidence that the presence of an ongoing systemic inflammatory response is a stage-independent predictor of poor outcome in patients with cancer. The aim of this study was to investigate whether an inflammation-based prognostic score, the prognostic nutritional index (PNI), is associated with overall survival (OS) in patients with hepatocellular carcinoma (HCC). METHODS: All patients with a new diagnosis of HCC presenting to the Medical Oncology Department, Hammersmith Hospital between 1993 and 2011 (n=112) were included. Demographic and clinical data were collected. Patients in whom the combined albumin (g l(-1)) × total lymphocyte count × 10(9) l(-1) was ≥45, at presentation, were allocated a PNI score of 0. Patients in whom this total score was <45 were allocated a score of 1. Univariate and multivariate analyses were performed to identify clinicopathological variables associated with OS. Independent predictors of survival identified on multivariate analysis were validated in an independent, stage-matched cohort of 68 patients. RESULTS: Univariate analyses showed that PNI (P=0.003), intrahepatic spread (P<0.001), the presence of extrahepatic disease (P=0.006), portal vein thrombosis (P=0.02), tumour multifocality (P=0.003), alfa-fetoprotein >400 ng ml(-1) (P<0.001) and Barcelona Clinic Liver Cancer score (P<0.01) were all predictors of OS in the training set. Multivariate analysis revealed the PNI (P=0.05), presence of extrahepatic disease (P<0.001) and degree of intrahepatic spread (P<0.001) as independent predictors of worse OS in this population. The PNI retained independent prognostic value in the validation set (P<0.001). CONCLUSION: The presence of a systemic inflammatory response, as measured by the PNI, is an independent and externally validated predictor of poor OS in patients with HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
(1998) · Hepatology · doi:10.1002/hep.510280322 · Cited by 1,238
(2011) · Hepatogastroenterology · doi:10.5754/hge11069 · Cited by 1,140
Diagnosis and Treatment of Hepatocellular Carcinoma
El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.090 · Cited by 1,137
Steel, D. M., & Whitehead, A. S. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90138-4 · Cited by 1,025
Systemic inflammation, nutritional status and survival in patients with cancer
McMillan, D. C. (2009) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32832a7902 · Cited by 1,001
Andreyev, H. J. N., Norman, A. R., Oates, J., & Cunningham, D. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10090-9 · Cited by 797
Ray-Coquard, I., Cropet, C., Van Glabbeke, M., Sebban, C., Le Cesne, A., Judson, I., Tredan, O., Verweij, J., Biron, P., Labidi, I., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3845 · Cited by 784
Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., Fletcher, C. D., O’Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.028 · Cited by 757
Nutritional predictors of postoperative outcome in pancreatic cancer
Kanda, M., Fujii, T., Kodera, Y., Nagai, S., Takeda, S., & Nakao, A. (2011) · Journal of British Surgery · doi:10.1002/bjs.7305 · Cited by 609
Kuang, D.-M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X.-Y., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.041 · Cited by 499
Gomez, D., Farid, S., Malik, H. Z., Young, A. L., Toogood, G. J., Lodge, J. P. A., & Prasad, K. R. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9552-6 · Cited by 402
Halazun, K. J., Hardy, M. A., Rana, A. A., Woodland, D. C., Luyten, E. J., Mahadev, S., Witkowski, P., Siegel, A. B., Brown, R. S., & Emond, J. C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a77e59 · Cited by 401
Inflammation and Liver Cancer: New Molecular Links
Berasain, C., Castillo, J., Perugorria, M. J., Latasa, M. U., Prieto, J., & Avila, M. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03704.x · Cited by 390
Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
Yusuf, R., Duan, Z., Lamendola, D., Penson, R., & Seiden, M. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033333754 · Cited by 354
Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
Huitzil-Melendez, F.-D., Capanu, M., O'Reilly, E. M., Duffy, A., Gansukh, B., Saltz, L. L., & Abou-Alfa, G. K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9895 · Cited by 335
Low preoperative serum albumin in colon cancer: a risk factor for poor outcome
Lai, C.-C., You, J.-F., Yeh, C.-Y., Chen, J.-S., Tang, R., Wang, J.-Y., & Chin, C.-C. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-010-1113-4 · Cited by 233
The Cancer Cachexia Syndrome: A Review of Metabolic and Clinical Manifestations
Esper, D. H., & Harb, W. A. (2005) · Nutrition in Clinical Practice · doi:10.1177/0115426505020004369 · Cited by 229
Canna, K., McArdle, P. A., McMillan, D. C., McNicol, A.-M., Smith, G. W., McKee, R. F., & McArdle, C. S. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602419 · Cited by 226
Rivory, L. P., Slaviero, K. A., & Clarke, S. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600448 · Cited by 218
Read, J. A., Boris Choy, S. T., Beale, P. J., & Clarke, S. J. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5501_10 · Cited by 182
Kinoshita, T., Ito, H., & Miki, C. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990615)85:12<2526::aid-cncr6>3.0.co;2-3 · Cited by 169
Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis
Carvalho, L., & Parise, E. R. (2006) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032006000400005 · Cited by 168
Cytokines in the pathogenesis of cancer cachexia
Argilés, J. M., Busquets, S., & López-Soriano, F. J. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000078983.18774.cc · Cited by 165
Read, J. A., Crockett, N., Volker, D. H., MacLennan, P., Choy, S. T. B., Beale, P. J., & Clarke, S. J. (2005) · Nutrition and Cancer · doi:10.1207/s15327914nc5301_6 · Cited by 141
Inflammation, HCC and sex: IL-6 in the centre of the triangle
Prìeto, J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.007 · Cited by 140
Chen, T., Lin, C., Huang, P., & Wen, C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06910.x · Cited by 137
Cancer cachexia: the molecular mechanisms
Argilés, J. M. A., Moore‐Carrasco, R., Fuster, G., Busquets, S., & López-Soriano, F. J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00251-0 · Cited by 132
Jee, S., Shen, S., Chiu, H., Tsai, W.-L., & Kuo, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204076 · Cited by 130
Nutritional and immunologic evaluation of patients with gastric cancer before and after surgery
Ferro, M. R., Castaño, R., Orozco, O., Serna, A. N., & Moreno, A. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00269-4 · Cited by 124
McKeown, D. J., Brown, D., Kelly, A. U., Wallace, A. M., & McMillan, D. C. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602248 · Cited by 118
Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma
Reynés, G., Vila, V., Martín, M. S., Parada, A., Fleitas, T., Regañón, E., & Martínez‐Sales, V. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0290-x · Cited by 106
Kemik, Ö., Sümer, A., Kemık, A. S., Hasırcı, İ., Purısa, S., Dülger, A. C., Demiriz, B., & Tüzün, S. (2010) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-8-85 · Cited by 102
Serum C‐reactive protein levels predict survival in hepatocellular carcinoma
Nagaoka, S., Yoshida, T., Akiyoshi, J., Akiba, J., Torimura, T., Adachi, H., Kurogi, J., Tajiri, N., Inoue, K., Niizeki, T., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01550.x · Cited by 100
Transcriptional Repression of HepaticCytochrome P450 3A4Gene in the Presence of Cancer
Charles, K. A., Rivory, L. P., Brown, S., Liddle, C., Clarke, S. J., & Robertson, G. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0023 · Cited by 79
Yang, Z., Yang, Z.-Y., Zhang, L.-D., PingBie, Wang, S., Ma, K., Li, X., & Dong, J. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.09.011 · Cited by 58
Nutritional status of patients undergoing lung cancer operations
Jagoe, R. T., Goodship, T. H. J., & Gibson, G. J. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)02005-1 · Cited by 55
Falleti, E., Fabris, C., Toniutto, P., Fontanini, E., Cussigh, A., Bitetto, D., Fumolo, E., Fornasiere, E., Bragagnini, W., Pinato, D. J., et al. (2009) · Oncology · doi:10.1159/000260057 · Cited by 40
Self-citation
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Tanaka, K., Fushiya, N., Koike, K., Nishino, H., & Matsushima, M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4048-0 · Cited by 442
Sun, K., Chen, S., Xu, J., Li, G., & He, Y. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1714-3 · Cited by 439
Okadome, K., Baba, Y., Yagi, T., Kiyozumi, Y., Ishimoto, T., Iwatsuki, M., Miyamoto, Y., Yoshida, N., Watanabe, M., & Baba, H. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000002985 · Cited by 391
Hong, X., Cui, B., Wang, M., Yang, Z., Wang, L., & Xu, Q. (2015) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.236.297 · Cited by 326
Metadata
- Authors
- Pinato, D. J., North, B. V., & Sharma, R.
- Venue
- British Journal of Cancer
- Published
- 2012-03-20
- Volume
- 106
- Issue
- 8
- Pages
- 1439-1445
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2041145044
- Cited by
- 421
- References
- 48
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.